This review demonstrates the anti-inflammatory potential of Lonicera japonica in inflammatory pathologies, suggesting implications for therapeutic development.
Inflammation is a complex biological response essential for tissue repair in acute settings, yet chronic dysregulation contributes to progressive tissue damage and the pathogenesis of numerous diseases. Lonicera japonica Thunb. (honeysuckle), a traditional Chinese medicinal herb renowned for its “heat clearing and detoxifying” properties, exhibits multi-target anti-inflammatory activity through synergistic modulation of inflammatory signaling cascades. This review systematically consolidates current knowledge regarding the anti-inflammatory bioactive components of honeysuckle and provides comprehensive insights into their therapeutic mechanisms. We focus on molecular targets, elucidating how honeysuckle constituents regulate key inflammatory pathways, thus offering a foundation for developing Lonicera japonica -based therapeutics against inflammation-driven pathologies. Additionally, we critically evaluate the challenges and limitations in translating these findings into clinical applications.
No takes yet. Share an insight, caveat, or question.
Niu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: